Emicizumab, sold under the brand name Hemlibra, is a humanized bispecific monoclonal antibody for the treatment of haemophilia A, developed by Genentech...

new form of gene therapy to treat haemophilia A. Monoclonal antibody emicizumab has been approved by the FDA in 2017 for therapy of hemophilia A. In July...

Amikacin liposome inhalation suspension Insmed mycobacterial lung disease Emicizumab-kxwh Genentech hemophilia Lorlatinib Pfizer ALK-positive, metastatic non-small...

Gazyva (obinutuzumab), for chronic lymphocytic leukaemia. Hemlibra (emicizumab), for haemophilia A. Herceptin (trastuzumab), for HER-2 positive breast...

of the disease previously had no approved treatments. 2017: Hemlibra (emicizumab): Treatment for haemophilia A. Developed by Chugai Pharmaceutical Co....

viral escape from the endosome and further infection. As an example, emicizumab (formerly RG6013) is an IgG derivative containing H-chain heterodimerization...

affected joint. In those with severe hemophilia A already receiving FVIII, emicizumab may provide some benefit. Different treatments are used to help those...

11/30/2015 intravenous humanized SLAMF7 Multiple myeloma 761035 Link emicizumab-kxwh Hemlibra Genentech 11/16/17 subcutaneous humanized, bispecific Factor...

hemophagocytic lymphohistiocytosis Emibetuzumab mab humanized HGFR cancer Emicizumab Hemlibra BsAb humanized activated F9, F10 Y haemophilia A Enapotamab vedotin...

Carbazochrome B02BX03 Batroxobin B02BX04 Romiplostim B02BX05 Eltrombopag B02BX06 Emicizumab B02BX07 Lusutrombopag B02BX08 Avatrombopag B02BX09 Fostamatinib B02BX10...

bromide (INN) Emete-Con emfilermin (INN) Emgel emicerfont (USAN, INN) Emicizumab emideltide (INN) emiglitate (INN) emilium tosilate (INN) emitefur (INN)...

analysis of ternary and binary binding modes of the bispecific antibody emicizumab". MAbs. 15 (1): 2149053. doi:10.1080/19420862.2022.2149053. PMC 9724730...